trapidil has been researched along with Heart Disease, Ischemic in 5 studies
Trapidil: A coronary vasodilator agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 7.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Adenosine and related compounds have been shown to produce atrioventricular (AV) conduction block during acute myocardial ischemia." | 3.78 | Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia. ( Hirayama, A; Kasamaki, Y; Kofune, M; Mano, H; Nagashima, K; Ohkubo, K; Okumura, Y; Sonoda, K; Watanabe, I, 2012) |
| "Aspirin was given to all patients, and ticlopidine 250 mg b." | 2.71 | Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. ( Balducelli, M; Barlera, S; Bernardi, G; Latini, R; Maggioni, AP; Maresta, A; Moccetti, T; Monici Preti, A; Ribeiro da Silva, EE; Sosa, C; Varani, E, 2005) |
| "Trapidil has shown a more complete antithrombocytic activity than other antiaggregating drugs; as a matter of fact it inhibits the formation of TXA2 through a mechanism of receptorial antagonism and at the same time it favours an increase of prostacyclina from the arterial walls." | 2.38 | [Trapidil after one year]. ( Agus, GB, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, I | 1 |
| Okumura, Y | 1 |
| Nagashima, K | 1 |
| Kofune, M | 1 |
| Ohkubo, K | 1 |
| Mano, H | 1 |
| Sonoda, K | 1 |
| Kasamaki, Y | 1 |
| Hirayama, A | 1 |
| Maresta, A | 1 |
| Balducelli, M | 1 |
| Latini, R | 1 |
| Bernardi, G | 1 |
| Moccetti, T | 1 |
| Sosa, C | 1 |
| Barlera, S | 1 |
| Varani, E | 1 |
| Ribeiro da Silva, EE | 1 |
| Monici Preti, A | 1 |
| Maggioni, AP | 1 |
| Agus, GB | 1 |
| Kotake, H | 1 |
| Sawada, Y | 1 |
| Hoshio, A | 1 |
| Shirota, K | 1 |
| Nawada, T | 1 |
| Yoshida, A | 1 |
| Hisatome, I | 1 |
| Miyakoda, H | 1 |
| Mashiba, H | 1 |
| Satoh, T | 1 |
| Otsuka, K | 1 |
| Sakurai, I | 1 |
1 review available for trapidil and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Trapidil after one year].
Topics: Anticoagulants; Arm; Arteriosclerosis; Brain Ischemia; Clinical Trials as Topic; Drug Evaluation; Hu | 1993 |
1 trial available for trapidil and Heart Disease, Ischemic
| Article | Year |
|---|---|
Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Vessel Prosthesis Implantation; Coronary Angiography; | 2005 |
3 other studies available for trapidil and Heart Disease, Ischemic
| Article | Year |
|---|---|
Effects of the antianginal drug trapidil on atrioventricular conduction disturbances during acute myocardial ischemia.
Topics: Adenosine; Angina Pectoris; Animals; Atrioventricular Block; Atrioventricular Node; Bundle of His; D | 2012 |
Effect of trapidil on serum lipid and apolipoprotein levels in patients with ischemic heart disease.
Topics: Aged; Apolipoproteins; Cholesterol, HDL; Female; Humans; Lipids; Male; Middle Aged; Myocardial Ische | 1993 |
[Method of quantitative measurement of human platelet aggregation in clinical practice].
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Dipyridamole; Epinephrine; Female; Humans; Male; Method | 1998 |